Confirming the protein analyses, a highly significant reduction in survivin gene expression was observed in both chondrosarcoma cell lines after treatment with 1.5 μM of the shikonin derivatives (Fig. 2b). This evidence concerns the gene BIRC5 and chondrosarcoma.